Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHANGE-AFIB: Early Dronedarone in First-Detected AF
NCT05130268Phase 4Completed
- Sponsor
- American Heart Association
- Start
- Oct 2021
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dronedarone in Atrial fibrillation (AFib), sponsored by American Heart Association. Started Oct 2021; status: completed.
02
Drugs
dronedarone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT05130268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05130268.